Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aminoglycoside adaptive resistance

J A Karlowsky1, S A Zelenitsky, G G Zhanel

  • 1Department of Medical Microbiology, University of Manitoba, Canada.

Pharmacotherapy
|May 1, 1997
PubMed
Summary

Aminoglycoside adaptive resistance reduces bacterial killing after initial drug exposure, particularly in Pseudomonas aeruginosa. This phenomenon, linked to decreased drug accumulation, requires further study, especially regarding combination therapy effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Moving towards a standardized definition of antimicrobial resistance: a comparison of the antimicrobial susceptibility profile of difficult-to-treat resistance (DTR) versus multidrug-resistant (MDR) Pseudomonas aeruginosa clinical isolates (CANWARD, 2016-2021).

Diagnostic microbiology and infectious disease·2023
Same author

Presence of the narrow-spectrum OXA-1 β-lactamase enzyme is associated with elevated piperacillin/tazobactam MIC values among ESBL-producing <i>Escherichia coli</i> clinical isolates (CANWARD, 2007-18).

JAC-antimicrobial resistance·2022
Same author

Antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential.

The Journal of antimicrobial chemotherapy·2017
Same author

Integrated pharmacokinetic-pharmacodynamic modelling to evaluate antimicrobial prophylaxis in abdominal surgery.

The Journal of antimicrobial chemotherapy·2016
Same author

Epidemiology of vancomycin-resistant enterococci in Canadian hospitals (CANWARD study, 2007 to 2013).

Antimicrobial agents and chemotherapy·2015
Same author

In vitro activity of oritavancin against Gram-positive pathogens isolated in Canadian hospital laboratories from 2011 to 2013.

Diagnostic microbiology and infectious disease·2014

Area of Science:

  • Microbiology
  • Bacterial Resistance Mechanisms
  • Pharmacodynamics

Background:

  • Aminoglycoside adaptive resistance is a reduced susceptibility observed in bacterial populations after initial exposure to aminoglycoside antibiotics.
  • This phenomenon is frequently documented in Pseudomonas aeruginosa and is associated with decreased intracellular drug accumulation.
  • The precise mechanisms and cellular components involved in aminoglycoside adaptive resistance in P. aeruginosa are not fully elucidated.

Purpose of the Study:

  • To explore the mechanisms and clinical relevance of aminoglycoside adaptive resistance.
  • To investigate the correlation between adaptive resistance and changes in bacterial cellular components and gene expression.
  • To discuss optimal therapeutic strategies and unresolved questions regarding aminoglycoside adaptive resistance.

Main Methods:

  • Observational studies and in vitro experiments analyzing bacterial susceptibility and drug accumulation.
  • Analysis of changes in cytoplasmic membrane proteins and gene expression related to anaerobic respiration.
  • Clinical case reviews and pharmacokinetic/pharmacodynamic (PK/PD) analysis.

Main Results:

  • Aminoglycoside adaptive resistance is linked to reduced intracellular drug accumulation in P. aeruginosa.
  • Adaptive resistance development coincides with alterations in cytoplasmic membrane proteins and regulated gene expression in the anaerobic respiratory pathway.
  • High peak concentration to minimum inhibitory concentration (MIC) ratios, achieved with once-daily dosing, may be beneficial for treating susceptible infections.

Conclusions:

  • Aminoglycoside adaptive resistance is a significant challenge, particularly in serious gram-negative rod infections.
  • Understanding the mechanisms of adaptive resistance is crucial for optimizing treatment strategies, especially in immunocompromised patients.
  • The impact of combination therapy on the development of aminoglycoside adaptive resistance remains a critical area for future research.

Related Experiment Videos